l General Information |
Product Name | Apabetalone(RVX208) |
General description | Apabetalone (RVX-208), a potent BET bromodomain inhibitor, has been investigated for the treatment of Diabetes, Atherosclerosis, and Coronary Artery Disease. |
Synonym | 2-[4-(2-hydroxyethoxy)-3,5-dimethylphenyl]-5,7-dimethoxy-1H-quinazolin-4-one; RVX 208; RVX-208 |
Purity | ≥98%(HPLC) | CAS Number | 1044870-39-4 |
Formula | C20H22N2O5 | Molecular Weight | 370.405 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | White or Off-white solid |
Solubility(25℃) | DMSO | ≥50mg/mL |
Ethanol | Insoluble |
Water | Insoluble |
l Biological Information |
Biochem/Physiol Actions | Apabetalone (RVX-208), a potent BET bromodomain inhibitor |
Application | Apabetalone has been investigated for the treatment of Diabetes, Atherosclerosis, and Coronary Artery Disease. |
l Packaging & Storage |
Packaging | 10mg; 50mg; 250mg |
Storage temp. | -20℃ |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
